Skip to content

Clinical trials

Phase 1/2 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 1/2 Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20042
20052
20063
20072
20081
20092
20101
20112
20124
20133
20144
20152
20163
20183
20196
20201
20212
20224
20231
20241
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status7
Recruiting5
Not yet recruiting4
Terminated4
Suspended3
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute4
Eli Lilly and Company2
Novartis Pharmaceuticals2
University of California, San Francisco2
University of Colorado, Denver2
VA Office of Research and Development2
Vishwajit Nimgaonkar, MD PhD2
Anya Bershad, MD, PhD1
Beth Israel Deaconess Medical Center1
Brian Miller1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia59
Psychotic Disorders21
Marijuana Abuse3
Anxiety Disorders1
Bipolar Disorder1
Constipation1
Hallucinations1
Inflammation1
Insulin Resistance1
Major Depressive Disorder1

Trials

Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.